Back to News
Market Impact: 0.42
Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack
Source: benzinga.com
Cybersecurity & Data PrivacyCorporate Guidance & OutlookCompany FundamentalsHealthcare & Biotech
Boston Scientific expects an August cybersecurity incident that disrupted global operations to materially hurt its Q3 and full-year 2026 financial results. The disruption creates a negative earnings and guidance risk for the medical-device maker, though the company did not disclose an estimated financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.55
Ticker Sentiment
BSX-0.85
More News
- Lab testing giant Quest Diagnostics confirms patients’ personal and health data was compromised during breach
- Next week brings major risks for the stock market, just as the AI trade keeps faltering
- What next for France as riots rattle markets? Three questions facing investors ahead of more protests
- Stocks Fall as Oil Rally Keeps a Lid on Treasuries
- Looters hit 3,000 French businesses. Within hours, the haul was trending on Vinted under the riot’s date
- Kinder Morgan, Energy Transfer and Williams could benefit from cheap natural gas